Renaissance Technologies - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,070
-2.9%
1,289,100
+11.6%
0.03%
+18.2%
Q2 2023$15,522
-14.1%
1,154,900
+5.9%
0.02%
-8.3%
Q1 2023$18,074
-21.1%
1,090,100
-11.5%
0.02%
-22.6%
Q4 2022$22,906
-99.9%
1,231,512
-44.7%
0.03%
-22.5%
Q3 2022$28,566,000
+295.0%
2,226,512
+115.8%
0.04%
+344.4%
Q2 2022$7,232,000
+147.1%
1,031,612
+192.1%
0.01%
+200.0%
Q1 2022$2,927,000
+2.2%
353,112
-16.5%
0.00%
-25.0%
Q4 2021$2,863,000
+933.6%
422,886
+709.5%
0.00%
Q3 2021$277,000
-90.3%
52,238
-92.9%
0.00%
-100.0%
Q1 2020$2,846,000
+331.9%
739,226
+320.7%
0.00%
+200.0%
Q4 2019$659,000
+14.2%
175,700
+15.0%
0.00%0.0%
Q3 2018$577,000
-84.7%
152,722
-90.1%
0.00%
-50.0%
Q2 2018$3,778,000
+13.8%
1,535,966
+10.5%
0.00%
-50.0%
Q1 2018$3,321,000
-23.8%
1,389,500
+24.7%
0.00%
-20.0%
Q4 2017$4,356,000
+197.1%
1,114,100
+91.6%
0.01%
+150.0%
Q3 2017$1,466,000
-40.4%
581,600
-34.8%
0.00%
-33.3%
Q2 2017$2,461,000
+229.9%
891,800
+133.2%
0.00%
+200.0%
Q1 2017$746,000
+4562.5%
382,400
+2449.3%
0.00%
Q3 2016$16,000
-92.2%
15,000
-91.5%
0.00%
Q1 2016$206,000
+123.9%
175,800
+728.2%
0.00%
Q1 2015$92,000
-85.9%
21,227
-89.2%
0.00%
-100.0%
Q3 2014$652,000
+54.5%
196,500
+41.9%
0.00%
+100.0%
Q3 2013$422,000138,5000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders